Search

everythinglearnresearchcommunity

for

Search:↓

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Metformin, a diabetes drug, may help prevent and treat various cancers, but more research is needed.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

Spermidine helps protect against aging by preserving telomere length.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

Researchers created a model to understand heart aging, highlighting key genes and pathways, and suggesting miR-208a as a potential heart attack biomarker.

Wnt/beta-catenin signaling in the skin helps fat cell development during hair growth and repair.

Fat-related cells are important for initiating hair growth.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

High levels of male hormones, insulin resistance, and obesity are closely linked and worsen polycystic ovary syndrome, but more research is needed to improve treatments.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

The niche environment controls stem cell behavior and plasticity, which is important for tissue health and repair.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The protein folliculin, involved in a rare disease, works with another protein to control how cells stick together and their organization, and changes in this interaction can lead to disease symptoms.

mTOR signaling helps activate hair stem cells by balancing out the suppression caused by BMP during hair growth.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.